$158.50
Today
as of Aug 5, 16:46 ET
Last 30 days
Recent Press Releases & News
Belite Bio Conference Highlights Tinlarebant Data and New Hope for Retinal Diseases
Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
Overview
52-week range
$56
$200
71% of range
Avg surprise (last 3)
+4.0%
Avg reaction (last 2)
+0.4%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 20, 2026 | Mar/2026 | $-0.34 | $-0.60 | +43.3% | +24.4% | +2.6% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.50 | $-0.47 | -6.4% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.45 | $-0.36 | -25.0% | — | -1.8% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.73 | -$0.50 | -46.0% |
Implied volatility — last 90 days
No IV snapshots yet for BLTE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.